Ivicentamab
Ivicentamab (GEN-3009) is an IgG1κ-type bispecific antibody targeting different epitopes of CD37. Ivicentamab can be used for cancer research[1].
Product Specifications
CAS Number
2364496-42-2
Product Name Alternative
GEN-3009
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ivicentamab.html
Purity
99.82
Solubility
10 mM in DMSO
Smiles
[Ivicentamab]
Molecular Weight
(144.88 kDa)
References & Citations
[1]Balocco Mattavelli. International Nonproprietary Names Programme and Classification of Medical Products. World Health Organization International Nonproprietary Names.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1145121-01 0.02 mg (E-Coli)
Recombinant Gluconacetobacter diazotrophicus NADH-quinone oxidoreductase subunit B 1 (nuoB1)
Sign In for Pricing
View Details MBS1145121-02 0.1 mg (E-Coli)
Recombinant Gluconacetobacter diazotrophicus NADH-quinone oxidoreductase subunit B 1 (nuoB1)
Sign In for Pricing
View Details MBS1145121-03 0.02 mg (Yeast)
Recombinant Gluconacetobacter diazotrophicus NADH-quinone oxidoreductase subunit B 1 (nuoB1)
Sign In for Pricing
View Details